PROM1 and colorectal carcinoma: Indeed, our findings also revealed that percentage of CD133+ cells in bulk CRC cells significantly increased after chemotherapy (i.e., 5-Fu and OXA) (Fig 2C and 2D), and furthermore, purified CD133+ cells are more resistant to chemotherapy-induced cell death (Fig 2A).